 |
Headquartered in Hungary, Gedeon Richter is an innovation-driven specialty pharmaceutical company, boasting the biggest pharmaceutical research centre in CEU. One of its latest achievements is the original antipsychotic, cariprazine, already marketed in the US for BD, schizophrenia and aMDD treatment and in most of the EU countries for treatment of schizophrenia in adult patients. |
 |
RECORDATI is an Italian Pharmaceutical Company, listed on the Italian stock exchange since 1984, produces and promotes a wide range of innovative products in around 150 countries, markets a number of specialties generated by its original research, its portfolio includes both products for primary and specialty care and treatment for rare diseases. |
Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research and today our products are available in more than 100 countries.
We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy.
Whether we work in labs, at desks or in the field, we are all tirelessly dedicated to restoring brain health, so every person can be their best.
www.lundbeck.com
At Boehringer Ingelheim Mental Health, we are redefining mental health to enable people to thrive. We link behavior to the underlying neurobiology to develop targeted therapies that can ease the burden of these conditions, not just the symptoms. By combining traditional treatment approaches with new and innovative approaches and technologies, we will enable those with mental health conditions such as Schizophrenia, Borderline Personality Disorder or Depression to create more meaningful connections to their lives, loved ones and society. Boehringer Ingelheim has a rich pipeline in all phases of development.
Mental Disorders | Boehringer Ingelheim (boehringer-ingelheim.com)
Supporters:
Informative supporters:
